Analysen von Mark Purcell
| 09.06.14 | Novartis Equal weight | Barclays Capital | |
| 21.05.14 | AstraZeneca Equal weight | Barclays Capital | |
| 14.04.14 | Bayer Equal weight | Barclays Capital | |
| 10.03.14 | Bayer Equal weight | Barclays Capital | |
| 10.03.14 | AstraZeneca neutral | Barclays Capital | |
| 10.03.14 | GSK Equal weight | Barclays Capital |